Used 2022 BTL Emsculpt Neo

 Sale Price: SOLD (OUT OF STOCK). CONTACT US FOR MORE INFO.

USED 2022 BTL Emsculpt Neo

What is EMSCULPT NEO

EMSCULPT NEO builds off the legacy of its predecessor, EMSCULPT, by simultaneously emitting both radio frequency and high intensity electromagnetic energies.

The end result is more fat reduction and muscle growth, than any single gold standard product, for less time and less money.

Best of all, EMSCULPT NEO has broad appeal as it can treat patients up to BMI 35!

How Does EMSCULPT NEO Work?

EMSCULPT NEO is based on an applicator simultaneously emitting  synchronized RF and HIFEM+ energies.

Due to the radiofrequency heating, the muscle temperature quickly raises by several degrees. This prepares muscles for exposure to stress, similar to what a warm up activity does before any workout. In less than 4 minutes, the temperature in subcutaneous fat reaches levels that cause apoptosis, i.e. fat cells are permanently damaged and slowly removed from the body. Clinical studies showed on average a 30% reduction in subcutaneous fat.*

Bypassing the brain limitations, HIFEM+ energy contracts the muscle fibers in the area at intensities that are not achievable during voluntary workout. Extreme stress forces the muscle to adapt resulting in an increase in the number and growth of muscle fibers and cells. Clinical studies* showed on average a 25% growth in muscle volume.

THE FIRST OF ITS KIND, EMSCULPT NEO® COMBINES RF AND HIFEM® TO SIMULTANEOUSLY ELIMINATE FAT AND BUILD MUSCLE.

In a world-first, EMSCULPT NEO®, by non-surgical body shaping leader BTL Aesthetics, combines its breakthrough HIFEM® high-intensity focused electromagnetic technology for muscle building with the fat-burning benefits of RF energy, introducing a patented concept of simultaneous application of RF and HIFEM®+. Combining RF and HIFEM®+ in a single applicator results in more fat reduction and muscle growth than any single gold standard product. Heating the muscles while burning fat allows for synergistic effects, with clinical studies showing EMSCULPT NEO®’s consistency in fat reduction and muscle increase. Studies have shown an average of 30% subcutaneous fat reduction and 25% increase in muscle mass. In addition, more than 30 scientific publications since 2018 make HIFEM® the most intensively researched technology used in non-invasive body shaping. With this unique, patented 2-in1 treatment, patients can gain more intense muscle-building and fat-reduction results all with the one device in as little as four 30-minute treatments.

EMSCULPT NEO® is the world’s fi rst FDA-cleared and TGA registered procedure to noninvasively eliminate fat cells and build muscle, by incorporating RF heating and high-intensity focused electromagnetic energy in a single modality. The new HIFEM®+ generates supramaximal contractions to activate 100% of the muscle fi bres at intensities unachievable through a voluntary muscle contraction, and the synchronised RF heat causes the muscle temperature to rise by several degrees (similar to a warmup activity before exercise). In less than four minutes, the temperature within the subcutaneous fat reaches levels that cause apoptosis. Fat cells are disrupted and fl ushed out of the body through the metabolic processes and heat shock proteins are activated which plays a crucial role in muscle hypertrophy. The combined energy also has the benefi cial eff ect of increased comfort, as patients are now able to reach higher muscle contraction intensities in a shorter time improving the treatment outcome. Traditionally, two standalone modalities are required to treat both fat and muscle. These conventional methods are outdated and have been proven less eff ective. EMSCULPT NEO® as a single solution can now allow patients to simultaneously burn through their fat stores while building muscles. This makes it a faster, economical and more effi cacious solution than combining multiple procedures. EMSCULPT NEO®’s fat reduction capabilities exceeds that of other popular body-sculpting technologies like cryolipolysis, which only reduces fat by 22%. With the ability to produce results across all body types, shorter treatment times, less treatment visits and minimal consumables, EMSCULPT NEO® off ers a solution with signifi cantly better profi tability in comparison with a combination of cryolipolysis and muscle stimulation. The other key factor is that EMSCULPT NEO® can now treat up to 9 applicable areas with the added RF, which were impossible to achieve with EMSCULPT®. These new areas include the inner thighs, outer thighs, front thighs and back thighs (as well as the traditional abdomen, buttocks, triceps, biceps and calves). This versatile solution provides inclusivity to most body types and has a broad patient appeal as we can now treat patients with higher to BMI of up to 35.

Can you briefly explain the science and mechanism action of EMSCULPT NEO® and how this influenced your decision to invest in the device?

EMSCULPT NEO® is the first and only non-invasive device to offer a unique blend of superior fat reduction and muscle building benefits by combining the two advanced technologies of RF and HIFEM® into one. This new approach addresses the two biggest patient concerns in a single treatment while unlocking the various synergistic benefits that can only be seen when the energies are simultaneously emitted. Traditionally, HIFEM® and RF cannot be emitted simultaneously in the same field without overheating the electrode as it consists of solid metal. To enable HIFEM® to pass through the RF without this heating phenomenon is an entirely new technology developed and patented by BTL. With the ability to synchronise the pulsations of RF with HIFEM®, we are now able to achieve a 30% reduction in fat, 25% increase in muscle mass, 19% decrease in diastasis recti and up to 5.9 cm circumferential waistreduction. These results are the highest statistics to date in this category and with over 30 peerreviewed publications to support HIFEM® technology, it is the most intensively researched technology used for body shaping. The supporting clinical data available are all evidence based with multiple histology samples, ultrasound, MRI, CT scans with over 30 investigators involved from independent test sites. Research shows the synergistic effect of dual emission documented an efficacy superior to any other standalone or consecutive treatment available on the market. To achieve greater gains than EMSCULPT NEO® over a one-month treatment plan would require invasive surgery.

BROAD APPEAL FOR BOTH PATIENTS AND PRACTITIONERS

World-first RF and HIFEM®+ for simultaneous fat reduction and muscle increase • Treats larger patient population with little BMI limitation (up to 35 BMI) • Fastest thermal effect on the market – apoptotic temperatures reached in less than four minutes • Automated temperature control • 30 minute treatment time x 4 treatments • Easy to use plug-n-play applicators for small and large areas • Reproducible results backed by 30+ clinical studies to support HIFEM® technology • Painless, comfortable, no-downtime treatment with high patient satisfaction